NCT01466179 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 189
- units
- Participants
- groups
- description
- Participants received blinatumomab by continuous intravenous (CIV) infusion over 4 weeks followed by a treatment-free interval of 2 weeks for up to 5 consecutive cycles. The initial dose was 9 μg/day for the first seven days of treatment, escalated to 28 μg/day starting from Week 2 of treatment.
- id
- BG000
- title
- Blinatumomab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 18
- upper Limit
- 79
- value
- 39.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- 18 to < 35 years
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- 35 to < 55 years
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- 55 to < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- ≥ 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 119
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- American Indian or Alaska native
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- Not recorded
- description
- Race was not permitted to be collected in France
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Primary refractory
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- Relapse ≤ 12 months of allogeneic HSCT
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- Entering first salvage; first remission ≤ 12 mo
- categories
- measurements
- group Id
- BG000
- value
- 108
- title
- Entering second or greater salvage therapies
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No criteria met
- description
- HSCT = hematopoietic stem cell transplantation
- param Type
- NUMBER
- title
- Disease stage entry criteria met
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 107
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- >2
- param Type
- NUMBER
- title
- Number of prior relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Prior allogeneic HSCT
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- No prior alloHSCT, no prior relapse
- categories
- measurements
- group Id
- BG000
- value
- 84
- title
- No prior alloHSCT, 1 prior relapse
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- No prior alloHSCT, 2 prior relapses
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No prior alloHSCT, > 2 prior relapses
- description
- alloHSCT = allogeneic hematopoietic stem cell transplantation
- param Type
- NUMBER
- title
- Prior allogeneic HSCT and prior relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- title
- No prior salvage therapy
- categories
- measurements
- group Id
- BG000
- value
- 77
- title
- 1 prior salvage therapy
- categories
- measurements
- group Id
- BG000
- value
- 42
- title
- 2 prior salvage therapies
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- > 2 prior salvage therapies
- param Type
- NUMBER
- title
- Number of prior salvage therapies
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 1.9
- upper Limit
- 249.0
- value
- 16.59
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since initial diagnosis
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 56.8
- value
- 1.38
- description
- Reported for 173 participants with a prior relapse (the other16 participants were primary refractory with no prior relapses).
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since last relapse
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- < 10%
- categories
- measurements
- group Id
- BG000
- value
- 43
- title
- 10% - < 50%
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- ≥ 50%
- description
- Bone marrow blasts were assessed by local and central laboratories; reported data are based on maximum central and local laboratory assessments.
- param Type
- NUMBER
- title
- Baseline bone marrow blast category
- unit Of Measure
- participants
- population Description
- Primary Analysis Set
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 189
- units
- Participants
- groups
- description
- Participants received blinatumomab by continuous intravenous (CIV) infusion over 4 weeks followed by a treatment-free interval of 2 weeks for up to 5 consecutive cycles. The initial dose was 9 μg/day for the first seven days of treatment, escalated to 28 μg/day starting from Week 2 of treatment.
- id
- BG000
- title
- Blinatumomab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 18
- upper Limit
- 79
- value
- 39.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- 18 to < 35 years
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- 35 to < 55 years
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- 55 to < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- ≥ 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 119
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- American Indian or Alaska native
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- Not recorded
- description
- Race was not permitted to be collected in France
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Primary refractory
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- Relapse ≤ 12 months of allogeneic HSCT
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- Entering first salvage; first remission ≤ 12 mo
- categories
- measurements
- group Id
- BG000
- value
- 108
- title
- Entering second or greater salvage therapies
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No criteria met
- description
- HSCT = hematopoietic stem cell transplantation
- param Type
- NUMBER
- title
- Disease stage entry criteria met
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 107
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- >2
- param Type
- NUMBER
- title
- Number of prior relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Prior allogeneic HSCT
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- No prior alloHSCT, no prior relapse
- categories
- measurements
- group Id
- BG000
- value
- 84
- title
- No prior alloHSCT, 1 prior relapse
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- No prior alloHSCT, 2 prior relapses
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No prior alloHSCT, > 2 prior relapses
- description
- alloHSCT = allogeneic hematopoietic stem cell transplantation
- param Type
- NUMBER
- title
- Prior allogeneic HSCT and prior relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- title
- No prior salvage therapy
- categories
- measurements
- group Id
- BG000
- value
- 77
- title
- 1 prior salvage therapy
- categories
- measurements
- group Id
- BG000
- value
- 42
- title
- 2 prior salvage therapies
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- > 2 prior salvage therapies
- param Type
- NUMBER
- title
- Number of prior salvage therapies
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 1.9
- upper Limit
- 249.0
- value
- 16.59
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since initial diagnosis
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 56.8
- value
- 1.38
- description
- Reported for 173 participants with a prior relapse (the other16 participants were primary refractory with no prior relapses).
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since last relapse
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- < 10%
- categories
- measurements
- group Id
- BG000
- value
- 43
- title
- 10% - < 50%
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- ≥ 50%
- description
- Bone marrow blasts were assessed by local and central laboratories; reported data are based on maximum central and local laboratory assessments.
- param Type
- NUMBER
- title
- Baseline bone marrow blast category
- unit Of Measure
- participants
- population Description
- Primary Analysis Set
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle